Seiji Isonishi Selected Research

Seiji Isonishi Research Topics

17	Ovarian Neoplasms (Ovarian Cancer) 11/2021 - 06/2004
15	Carcinoma (Carcinomatosis) 01/2019 - 08/2002
15	Neoplasms (Cancer) 01/2019 - 02/2002
6	Ovarian Epithelial Carcinoma 09/2014 - 08/2002
2	Hypersensitivity (Allergy) 11/2019 - 12/2011
2	Adenocarcinoma 04/2017 - 01/2017
2	Breast Neoplasms (Breast Cancer) 02/2008 - 04/2004
2	Prostatic Neoplasms (Prostate Cancer) 10/2005 - 04/2004
1	Peritoneal Neoplasms 04/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017
1	Lymphatic Metastasis 01/2017
1	Adenosquamous Carcinoma 01/2017
1	Clear Cell Adenocarcinoma 10/2016
1	Ascites 10/2016
1	Hypoxia (Hypoxemia) 10/2016
1	Anorexia 01/2016
1	Nausea 01/2016
1	Vomiting 01/2016
1	Neutropenia 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2016
1	Arthralgia (Joint Pain) 01/2016
1	Diarrhea 01/2016
1	Leukopenia 01/2016
1	Febrile Neutropenia 01/2016
1	Pleural Effusion (Pleural Effusions) 03/2015
1	Disease Progression 04/2013
1	Hepatocellular Carcinoma (Hepatoma) 02/2009
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 02/2009
1	Residual Neoplasm 02/2009
1	Small Cell Carcinoma 04/2008
1	Stomach Neoplasms (Stomach Cancer) 02/2008
1	Colonic Neoplasms (Colon Cancer) 02/2008
1	Lung Neoplasms (Lung Cancer) 04/2004
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2004
1	Colorectal Neoplasms (Colorectal Cancer) 01/2004

10	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 08/2002
9	PlatinumIBA 11/2019 - 06/2006
7	Carboplatin (JM8)FDA LinkGeneric 11/2019 - 10/2009
6	Pharmaceutical PreparationsIBA 11/2019 - 06/2004
6	taxaneIBA 01/2019 - 06/2006
6	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 08/2003
3	Docetaxel (Taxotere)FDA Link 04/2017 - 02/2009
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2004
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2016 - 04/2008
2	orobolIBA 07/2007 - 08/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016
1	O,N-carboxymethylchitosan (NOCC)IBA 10/2016
1	Thyroglobulin FDA Link 07/2016
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2016
1	GlycolipidsIBA 12/2012
1	Proteins (Proteins, Gene)FDA Link 12/2012
1	Taxoids (Taxanes)IBA 12/2011
1	Interferon-alpha (Interferon Alfa)IBA 05/2011
1	AntigensIBA 02/2009
1	CarbohydratesIBA 02/2009
1	Carcinoembryonic AntigenIBA 02/2009
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2009
1	Keratins (Keratin)IBA 02/2009
1	CAM 5.2 antigenIBA 02/2009
1	Fetal Proteins (Fetoprotein)IBA 02/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2008
1	Biological ProductsIBA 04/2008
1	Hormones (Hormone)IBA 02/2008
1	Antineoplastic Agents (Antineoplastics)IBA 02/2008
1	Platelet-Derived Growth FactorIBA 07/2007
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 08/2005
1	Tumor Biomarkers (Tumor Markers)IBA 07/2004
1	Cytochromes c (Cytochrome c)IBA 08/2003
1	Platinum Compounds (Compounds, Platinum)IBA 08/2002

20	Drug Therapy (Chemotherapy) 11/2019 - 08/2002
7	Therapeutics 01/2017 - 02/2002
3	Lymph Node Excision (Lymph Node Dissection) 02/2009 - 08/2002
3	Cytoreduction Surgical Procedures 02/2009 - 08/2002
2	Salpingo-oophorectomy 04/2017 - 02/2009
2	Hysterectomy 04/2017 - 02/2009
2	Laparotomy 04/2017 - 08/2002
1	Neoadjuvant Therapy 11/2021
1	Adjuvant Chemotherapy 04/2017
1	Adjuvant Radiotherapy 01/2017
1	Radiotherapy 01/2017
1	Chemoradiotherapy 01/2017
1	Treatment Delay 03/2015
1	Thoracotomy 03/2015
1	Combination Drug Therapy (Combination Chemotherapy) 04/2013
1	Maintenance Chemotherapy 04/2013
1	Chemoprevention 10/2005
1	Salvage Therapy 08/2002
1	Conservative Treatment 08/2002